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Abstract—In this paper, we introduce a novel and interpretable
methodology to cluster subjects suffering from cancer, based on fea-
tures extracted from their biopsies. Contrary to existing approaches,
we propose here to capture complex patterns in the repartitions of
their cells using histograms, and compare subjects on the basis of
these repartitions. We describe here our complete workflow, including
creation of the database, cells segmentation and phenotyping, com-
putation of complex features, choice of a distance function between
features, clustering between subjects using that distance, and survival
analysis of obtained clusters. We illustrate our approach on a database
of hematoxylin and eosin (H&E)-stained tissues of subjects suffering
from Stage I lung adenocarcinoma, where our results match existing
knowledge in prognosis estimation with high confidence.
Keywords—Cancer, clustering, histograms, survival analysis,
Wasserstein distance.
I. INTRODUCTION
PERSONALIZED oncololgy aims at improving the sur-vival outcome of a subject, by understanding deeply
their disease using attributes that are specific to their own
metabolism. Among techniques that analyze biopsies of tu-
mors, most works characterize subjects based on quantitative
attributes, such as the number of tumor-infltrating lymphocytes
(TILs) [1], their density and area [2], or the immunoscore
[3]. However, it has been recently shown that more global
organizations of cells – and in particular TILs – can have a
strong impact on the survival prognosis [4], [5], [6].
In this work, we introduce a novel methodology to capture
in details complex repartitions of cells within the tissues. Our
approach can be used at various scales (cell level, clusters of
cells level, etc.), thus providing numerous and complementary
information regarding the tissue.
Contrary to existing approaches such as [6], we do not
classify the subjects in pre-defined classes. Instead, we propose
to work in a non-supervised way, to group subjects based on
their similarities regarding the defined features. This allows 1)
exploration of new features that may correlate with survival;
and 2) research of similar subjects for a newly seen person.
Our work is organized as follows: in Section II, we give
an overview of our method and its inputs; in Section III, we
define some features that capture particular organizations of
cells; then, in Section IV, we explain which distance function
we use, as well as our choice of clustering algorithm; finally,
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in Section V, we illustrate our methodology on a database
of H&E-stained biopsies of subjects suffering from Stage I
lung adenocarcinoma, and show that our results match existing
knowledge in the field.
II. OVERVIEW OF THE METHODOLOGY
Biopsies are provided in the form of high-resolution scans
of a tissue, which have been previously stained to reveal cell
kernels. H&E has been the most commonly used staining for
years due to an easy and cheap acquisition of these images.
Still, more complex techniques such as multiplex immuno-
histochemistry (mIHC) have been developed, which allow
capturing richer information on the cells such as distinction
of CD8/CD4/CD3 lymphocytes, albeit at a higher cost.
Once a high-resolution image has been acquired, a common
practice is to perform its segmentation and phenotyping, in or-
der to localize and characterze all cells. For H&E images, tools
using deep learning models [7] have recently shown impressive
performance in finding cells and associating them with a
phenotype (cancer/stroma/lymphocyte). Proprietary tools exist
for mIHC [8], as well as more recent solutions, here again
involving deep learning models [9]. All of these tools output
similar information. For each cell kernel found, they provide at
least the following attributes: x coordinate, y coordinate, and
phenotype. Available phenotypes depend on the staining
technique, and more attributes can be output depending on
the tools (e.g., Keratin, PDL1, etc.).
Our methodology takes as an input a set S =
{s(i)}i∈{1,...,|S|} of subjects. For each subject s ∈ S, we have
a set Cs = {c(i)}i∈{1,...,|Cs|} of cells. Each cell c ∈ Cs has a
given number of attributes, which we can access as c[a], with
a ∈ {x,y,phenotype, . . . }.
From there, our method proceeds as follows:
1) Let H be the set of histograms. Design a set F = {f (i) :
S → H}i∈{1,...,|F|} of features of interest, which are
functions that associate a subject s ∈ S with a histogram
H
(i)
s ∈ H. Examples of features are given in Section III;
2) Evaluate all features on all subjects to obtain histograms
{H(i)s }s∈S,i∈{1,...,|F|}.
3) For each feature f (i) ∈ F , and each two distinct subjects
s(j), s(k) ∈ S , compute the |S| × |S| distance matrix
D(i)[j, k] = dH
(
H
(i)
s(j)
, H
(i)
s(k)
)
. Details on the distance
function dH are given in Section IV;
4) For each matrix D(i), feed it to a clustering algorithm,
that will output a partition of S based on their similarity
with respect to feature f (i). Details on the algorithm are
given in Section IV;
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5) Perform survival analysis of the sub-populations found
this way to evaluate significance of the impact of f (i)
on survival prognosis.
Alternatively, step 3) can be changed to first compute a
matrix D which aggregates the various D(i) associated with
individual features. This allows merging information captured
by the features into one global matrix, which can be used as an
input for the clustering algorithm. Details on the aggregation
are given in Section IV-C.
III. PROPOSED FEATURES
In this section, we propose five features that capture some
interesting cell repartitions within the tissues1. Each feature
is a function f (i) : S → H that inputs a subject s ∈ S
with cells Cs, and outputs a histogram H(i)s ∈ H. In the
following, function values to hist(V ) transforms a set V of
values into a histogram which associates each value v ∈ V
with its number of occurrences in V .
In order to simplify features definition, we first introduce a
notion of filtering. Let C−s ⊆ Cs be any subset of the cells Cs
of subject s ∈ S. We note C−s [P ] ⊆ C−s the subset of cells in
C−s for which a proposition P : C−s → B is true.
As an example, remember from Section II that cells
are given some attributes, including their phenotypes. As-
sume here the attribute phenotype can take values in
{"cancer","stroma","lymphocyte"}, we can define
the following filter:
lymph : C−s → B
c 7→ c[phenotype] = "lymphocyte" .
(1)
Using this filter, we can get all lymphocytes in Cs as
Cs[lymph]. Similarly, we can easily define filters stroma and
cancer that return cells of corresponding phenotypes.
A. f (1): distances lymphocytes – cancer cells
Let us consider a subject s ∈ S with cells Cs. In a first
feature, we want to capture the proximity between lympho-
cytes and cancer cells. Each computed value will then be the
minimum distance between a lymphocyte and all cancer cells.
To simplify this definition, we introduce a filter that, given
a reference cell c ∈ Cs, returns the cell within the set C−s ⊆ Cs
being filtered which minimizes Euclidean distance to c:
closest(c) : C−s → B
c′ 7→ c′ = arg min
c′′∈C−s
dxy(c
′′, c) ,
(2)
where:
dxy(c, c
′) =
√
(c′[x]− c[x])2 + (c′[y]− c[y])2 . (3)
Using this filter, Algorithm 1 details computation of H(1)s .
Informally, Cs[cancer][closest(c)] can be translated as the
cancer cell which is the closest to the given cell c.
1Codes for all subsequent functions will be made available upon acceptance.
Algorithm 1 f (1)(s)
V := {}
for all c ∈ Cs[lymph] do
d := dxy(c, Cs[cancer][closest(c)])
V := V ∪ {d}
end for
H
(1)
s := values to hist(V )
return H(1)s
B. f (2): distances lymphocytes – cancer/stroma interface
In a second feature, we want to capture the proximity
between lymphocytes and the cancer/stroma interface. Each
computed value will then be the minimum distance between
a lymphocyte and a cancer cell at that interface.
To simplify the definition of this feature we again introduce
a new filter, that formalizes the notion of interface between
cell types. Let C−s ⊆ Cs and C−
′
s ⊆ Cs be two non-intersecting
subsets of the cells. Additionally, let Ts be the set of triangles
obtained by the Delaunay triangulation [10] of the cells in Cs,
built from the x and y cell attributes (see Figure 1 for an
example of this triangulation). Each triangle t ∈ Ts is the set
of three cells that define it. We can define the filter:
inter(C−′s ) : C−s → B
c 7→ ∃t ∈ Ts : c ∈ t
and ∃c′ ∈ t : c′ ∈ C−′s ,
(4)
which returns the subset of cells in C−s that are spatially close
to cells in C−′s , by checking existence of a triangle defined by
cells of both subsets. This allows an easy definition of filters
to obtain cells located at the border between two cell types,
such as cancer and stroma for instance. Stroma cells at that
interface are thus Cs[stroma][inter(Cs[cancer])] and cancer
ones Cs[cancer][inter(Cs[stroma])].
Using this filter, Algorithm 2 details computation of H(2)s .
It is worth noting that we distinguish between lymphocytes
that are within a cancer environment and those that are in a
stroma environment by checking on which side of the interface
they are located. The former will be associated with a negative
distance in the histogram.
Algorithm 2 f (2)(s)
V := {}
for all c ∈ Cs[lymph] do
dc := dxy(c, Cs[cancer][inter(Cs[stroma])][closest(c)])
ds := dxy(c, Cs[stroma][inter(Cs[cancer])][closest(c)])
if dc < ds then
dc := −dc
end if
V := V ∪ {dc}
end for
H
(2)
s := values to hist(V )
return H(2)s
C. f (3): distances between aggregates of lymphocytes
This third feature catpures the proximity between dense
aggregates of cells. Each computed value will be the minimum
distance between an aggregate of lymphocytes and the other
aggregates of such cells.
Once again, we simplify the definition of the feature by
introducing a filter that will only keep cells that belong to
the same aggregate. To do so, we again use the Delaunay
triangulation of the cells. Let Es be the set of edges in the
Delaunay triangulation. Then, let C−s ⊆ Cs be a subset of the
cells, and let E−s ⊆ Es be the subset of edges that connect
two cells in C−s . The graph Gs made of vertices C−s and edges
E−s consists of disjoint connected components, which we note
{G(i)s }i∈{1,...,|Gs|}. We now define the following filter:
cc(i) : C−s → B
c 7→ c ∈ G(i)s .
(5)
Using this filter, Algorithm 3 details computation of H(3)s .
Informally, Cs[lymph][cc(j)][closest(c)] can be translated as
the cell in the jth aggregate of lymphocytes which is the closest
to the given cell c.
Algorithm 3 f (3)(s)
V := {}
for all i do
di :=∞
for all j, j 6= i do
dij :=∞
for all c ∈ Cs[lymph][cc(i)] do
dij := min(dij , dxy(c, Cs[lymph][cc(j)][closest(c)]))
end for
di := min(di, dij)
end for
V := V ∪ {di}
end for
H
(3)
s := values to hist(V )
return H(3)s
D. f (4): sizes of the aggregates of lymphocytes
This fourth feature catpures the variety of sizes among
aggregates of lymphocytes. Each computed value will be the
number of lymphocytes in an aggregate of such cells.
Algorithm 4 details computation of H(4)s .
Algorithm 4 f (4)(s)
V := {}
for all i do
ni := |Cs[lymph][cc(i)]|
V := V ∪ {ni}
end for
H
(4)
s := values to hist(V )
return H(4)s
E. f (5): densities of lymphocytes at cancer/stroma interface
Finally, this fifth feature catpures the densities of lym-
phocytes in bands around the cancer/stroma interface. Each
computed value will be the density of lymphocytes among all
cells located in a certain interval of distance from interface
cells. As for feature f (2), we make the distinction between
bands within the cancer environment and those within the
stroma environment, by associating negative bins with the
former. We have chosen to consider bands of 20µm to include
multiple cells (as kernel size of the considered tissues is
approximately 7− 8µm).
Algorithm 5 details computation of H(5)s .
Algorithm 5 f (5)(s)
band width := 20
nb cells := {}
nb lymph := {}
for all c ∈ Cs do
dc := dxy(c, Cs[cancer][inter(Cs[stroma])][closest(c)])
ds := dxy(c, Cs[stroma][inter(Cs[cancer])][closest(c)])
if dc < ds then
dc := −dc
end if
band := dc//band width # Euclidean division
if band 6∈ nb cells then
nb cells[band] := 0
nb lymph[band] := 0
end if
nb cells[band] := nb cells[band] + 1
if c[phenotype] = "lymphocyte" then
nb lymph[band] := nb lymph[band] + 1
end if
H
(5)
s := {}
for all band ∈ nb cells do
H
(5)
s [band] :=
nb lymph[band]
nb cells[band]
end for
end for
return H(5)s
IV. DISTANCES BETWEEN FEATURES, AND CLUSTERING
A. A distance function between histograms
In Section III, we have introduced a few features that
capture various repartitions of particular types of cells. Each
of these features takes the form of a histogram, which is a
richer representation than simple numerical features.
The idea of what comes next is to cluster subjects based
on the repartitions of cells captured by these histograms. This
implies the necessity to choose a distance function dH between
histograms that complies with the captured information, i.e.,
for two histograms H(i)s and H
(i)
s′ – obtained by evaluating
feature f (i) on two subjects s, s′ ∈ S – we want the distance
dH(H
(i)
s , H
(i)
s′ ) to be low when both histograms have similar
shapes around the same values; and to increase as their shapes
or locations differ.
A good candidate is therefore the Wasserstein distance
between distributions (see e.g., [11]). This distance measures
the quantity of work required to transform a distribution
into another one. More formally, given two (positive, unit-
sum) histograms H1 and H2, it is obtained by solving an
optimization problem defined as:
dwass(H1, H2) = min
T
∑
h1,h2
T[h1, h2]C[h1, h2]
s.t. T1 = H1; T>1 = H2; T ≥ 0 ,
(6)
where C is the matrix that defines the cost to move a unit of
mass from the hth1 bin of distribution H1 to the h
th
2 bin of
distribution H2. A solution to the problem is a matrix T of
optimal transport between histogram H1 and H2. This problem
is of complexity O(n3). However, solvers are very efficient
and make its resolution very tractable [12].
As this distance is defined on distributions, we must there-
fore normalize our histograms so that the sum of values equals
1. A direct consequence of this is that we cannot distinguish
some histograms anymore. A simple example is – on one side
– a histogram consisting of a unique bin at 0 with value 10;
and – on the other side – a histogram consisting of a unique
bin at 0 with value 100. After normalization, both distributions
feature a unique bin at 0 of value 1.
At first glance, this may seem problematic, as some features
such as f (1) enforce a direct relation between the number
of lymphocytes in the tissue and the number of histogram
entries. However, such quantitative aspects can be included as
numerical features during classification if one wants to include
the total number of lymphocytes as a feature. Additionally, this
normalization does not change the shape of the histogram,
which allows us to compare – taking again the example of
f (1) – the repartitions of lymphocytes around cancer cells.
In the remaining of this document, we will therefore use
Wasserstein distance dwass between our histograms for dH,
assuming both histograms H(i)s and H
(i)
s′ – obtained by evalu-
ating feature f (i) on two subjects s, s′ ∈ S – have previously
been normalized, i.e.,
dH
(
H(i)s , H
(i)
s′
)
= dwass
 H(i)s∣∣∣H(i)s ∣∣∣
1
,
H
(i)
s′∣∣∣H(i)s′ ∣∣∣
1
 , (7)
where | · |1 denotes the `1 norm of all values in the histogram.
The cost matrix C in Equation 6 is chosen to be linear, i.e.
if there is a bin at value h1 and a bin at value h2, the cost
C[h1, h2] for transporting a unit of mass between h1 and h2
is |h1 − h2|. Dimension of C is chosen so that each distinct
value in H(i)s and H
(i)
s′ has its own bin.
B. Clustering of the subjects
Now that we have defined a distance function that compares
the shapes of distributions captured by our features, we can
cluster all subjects in S – in a non-supervised way – to group
together those that have similar repartitions of cells.
For each feature f (i) ∈ F , and any pair of subjects
s(j), s(k) ∈ S, we can now compute a |S| × |S| matrix:
D(i)[j, k] = dH
(
H
(i)
s(j)
, H
(i)
s(k)
)
. (8)
We can now feed D(i) to a clustering algorithm to assess
the abiliy of the feature to create meaningful sub-populations.
Because of its high interpretability, we have chosen to use as-
cending hierarchical classification (AHC) with single-linkage
[13] as our clustering algorithm. Starting with each subject into
their own cluster, this algorithms iteratively merges clusters
– chosen to minimize dissimilarity between merged clusters
– until the entire population belongs to the same cluster.
This way, it produces a dendrogram, in which the leaves are
individual subjects. As a consequence, the deeper we go in
the dendrogram (toward its leaves), the more homogeneous
the clusters we find are.
Based on D(i), we use AHC to partition S into two disjoint
sub-populations S = S(i)1 unionsq S(i)2 as follows:
• The first sub-population S(i)1 ⊆ S is obtained by cutting
the dendrogram at a threshold τAHC, and keeping the
deepest resulting sub-tree. By construction, this sub-
population will be homogeneous with respect to the
feature used to build the input distances matrix;
• The second sub-population S(i)2 ⊆ S is obtained by
merging all subjects that do not belong to the first one.
By construction, these subjects will be dissimilar with
respect to the feature.
The reasoning behind this approach is that we want to
verify whether having one particular distribution of cells is
characteristic of the survival prognosis, assuming the subjects
without that particular distribution may have very personal –
diverse – profiles.
In order to determine the value of the threshold τAHC that
will separate sub-populations, we have made an exhaustive
search over its possible values. Then, for each two result-
ing sub-populations S(i)1 and S(i)2 , we have computed their
Kaplan-Meier survival curves [14], and have performed a log-
rank test [15] to assess how different they are. We have then
kept the value of τAHC which minimizes the p-value of that test,
i.e., which most significantly separates the two survival curves.
The idea behind this choice is to maximize the homogeneity
of S(i)1 without any prior on the size of the clusters.
C. Using multiple features
In the previous paragraphs, we have explained how to
cluster subjects based on a single matrix of distances, asso-
ciated with one particular feature. In practice, we would like
to combine the various features we have defined, to group
together subjects that tend to behave similarly on multiple
aspects.
To do so, we want to build a matrix D that captures the fact
that two subjects tend to belong to the same clusters S(i)1 or
S(i)2 , for each feature f (i) ∈ F . Additionally, we want to be
able to give more importance to some features in that global
matrix, to allow a pathologist to inject additional knowledge
in the aggregation.
Let s(j), s(k) ∈ S be two subjects. The requirements
described previously can be integrated in the computation of
D as follows:
D[j, k] =
|F|∑
i=1
w(i) · same
(
sj , sk,S(i)1
)
, (9)
where:
same
(
sj , sk,S(i)1
)
=

0 if (sj ∈ S(i)1 and sk ∈ S(i)1 )
or (sj 6∈ S(i)1 and sk 6∈ S(i)1 )
1 otherwise ,
(10)
and where {w(i)}i∈{1,...,|F| are given real values, weighting
the importance of features in the combination. Their values
can be determined either using expert knowledge, or more
agnostic methods, as proposed in Section V-C.
In Equation 9, the higher the value in D[j, k], the more
subjects s(j) and s(k) tend to belong to different clusters.
V. EXPERIMENTS
A. Database used
In order to evaluate our approach, we have chosen to
focus on Stage I lung adenocarcinoma. We have extracted
all corresponding subjects from the Cancer Genome Atlas
(TCGA) repository [16] to create a population S of 140
subjects. For each of these subjects, the TCGA repository
provides us with high resolution scans of the subject’s biopsy,
stained with H&E, as well as clinical information, including
the subject’s time to last follow-up (TTLFU) and alive state
at that time. When combined, these two pieces of information
allow us to compute the Kaplan-Meier survival estimator of
the population.
From these 140 subjects, we have chosen to remove those
that were alive with a too small TTLFU (for which we don’t
have enough hindsight), as well as those that were dead with a
too high TTLFU (as their tumor may have evolved too much
since diagnosis). We have therefore set up a threshold TTLFU
τDB, below which alive subjects are dropped, and above which
dead subjects are dropped. The value of τDB = 366 days has
been chosen to maximize the database size while encouraging
these criteria. After this filtering, our database consists of 115
subjects, 97 of which have an alive state.
For each subject, we have considered one scan of their
biopsy, and have defined multiple regions of interest (ROIs),
chosen at hand to be located in areas that appear to include
both cancer and stroma cells, mostly located at the tumor
border. The number of ROIs defined this way depends on the
size and contents of the image. Figure 1 depicts an example
of ROI selection in a tissue.
For each identified ROI, we have segmented and phenotyped
the cells in presence using the ConvPath tool [7]. Each
cell is therefore associated with the following attributes: x
coordinate, y coordinate and phenotype, that last one taking
values in {"cancer","stroma","lymphocyte"}.
Finally, to enforce our prior during ROIs selection, we have
filtered out those in which the ratio of cancer/stroma cells was
not in the [0.3, 0.7] interval. After this second filtering, we have
as an input a database of 94 subjects, 80 of which have an
alive state. Each of them is associated with 1 to 9 ROIs, with
TABLE I
SURVIVAL ANALYSIS OF THE POPULATION, BASED ON THE PROPOSED
FEATURES, TAKEN INDIVIDUALLY.
Feature
∣∣∣S(i)1 ∣∣∣
|S|
∣∣∣S(i)2 ∣∣∣
|S| p-value
f (1) 0.55 0.45 0.0574
f (2) 0.31 0.69 0.0002
f (3) 0.52 0.48 0.0124
f (4) 0.64 0.36 0.0151
f (5) 0.19 0.81 0.0005
an average of 3.86 ROI per subject. In the remaining of these
documents, features for a subject will be computed per ROI,
and aggregated in a single histogram before normalization.
B. Individual results per feature
First, we want to assess if the features we have proposed in
Section III are significantly correlating with survival prognosis.
To do so, we apply our methodology for each feature proposed
in Section III.
Table I presents the obtained results per feature. For each
feature f (i) ∈ F , we report respective sizes of resulting sub-
populations S(i)1 and S(i)2 . Significance of the clustering is
analyzed through the log-rank test of Kaplan-Meier estimators
between both sub-populations. The p-value of that test is given
in the last column2.
Results show that features f (2), f (3), f (4) and f (5) separate
survival curves significantly (p-value < 0.05). More precisely,
f (2) and f (5) have a strong statistical significance (p-value
 0.05).
We show in Figures 2, 3, 4, 5 and 6 (top) the survival
curves obtained by AHC for each feature f (i) ∈ F , for which
we are reporting results in Table I. In these figures, the orange
curve is the survival curve for the cluster of subjects that are
homogeneous to the feature (S(i)1 ), and the blue curve is the
survival curve for the cluster of heterogeneous subjects (S(i)2 ).
Shaded areas delimit a confidence interval of 95%.
Additionally, we show in these figures two histograms per
feature. The first one (left) is the most central histogram within
the cluster of homogeneous subjects, i.e., the histogram H(i)s∗
that minimizes:
H
(i)
s∗ = arg min
s∈S(i)j
∑
s′∈S(i)j
dH
(
H(i)s , H
(i)
s′
)
, (11)
where j ∈ {1, 2} is the considered sub-population. The second
histogram (right) is the most central within the heterogeneous
cluster, using that same centrality measure.
The corresponding subjects can be seen as representatives
for their clusters with respect to the feature f (i) ∈ F used.
Analyzing their histograms allows one to have an easy inter-
pretation of the results of the clustering algorithm, which helps
the pathologist understand the key aspects within distributions.
2All codes used to obtain these results will be made available upon
acceptance.
Fig. 1. Manual selection of ROIs on a subject’s SVS slide (top left), closeup on one of the selected ROIs (top right), and representation of the Delaunay
triangulation of the cells in that ROI (bottom). In that representation, lymphocytes are depicted in green, cancer cells in red and stroma cells in blue. ROIs
are selected to include both cancer and stroma cells in reasonable quantities.
C. Results obtained by combining features
Now that we have studied the proposed features individ-
ually, we propose to merge those that have shown enough
significance in survival prognosis into a unique matrix D, as
presented in Section IV-C.
In order to fix the values of weights {w(i)}i in Equation 9,
we propose to give more importance to features that are more
statistically significant than the others. For a feature f (i) ∈ F ,
let p(i) be the p-value of the log-rank test between survival
curves of clusters S(i)1 and S(i)2 , as reported in Table I. We
choose w(1) = 0 – due to low significance of the feature –
and {w(i)}i∈{2,...,|F|} as follows:
w(i) = log
(
1
p(i)
)
. (12)
The log in Equation 12 has been introduced to prevent
very significant features such as F (2) and F (5) to absorb the
contribution of other features.
Using the matrix D computed as in Equation 9 with
weights in Equation 12, we then use AHC and obtain two
subpopulations S1 and S2, of which Kaplan-Meier survival
curves are given in Figure 7. The log-rank test between these
curves has a p-value of 7.36 · 10−8, which indicates a very
strong significance of the clustering.
D. Discussion
A first observation in our results is that Feature f (1) is
not significant enough (p-value > 0.05). As a reminder, this
feature captures the distances between lymphocytes and their
closest cancer cells. When introducing it, we expected to
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Fig. 2. Survival curves associated with both sub-populations S(1)1 and S(1)2 obtained by AHC using D(1) (top); histogram H(1)s∗1 associated with the most
central subject s∗1 ∈ S(1)1 (alive, TTLFU 2973 days) of the first sub-population S(1)1 , obtained by feeding D(1) to the AHC clustering algorithm (bottom
left); and corresponding histogram H(1)
s∗2
(alive, TTLFU 466 days) of the central subject s∗2 ∈ S(1)2 of the other sub-population S(1)2 (bottom right).
find that subjects with a good survival prognosis would tend
to have a strong proximity between such cells, as having
lymphocytes in contact with cancer cells would indicate an
immune response to the tumor. However, a more careful
inspection of the feature reveals that it does not take into
account the information that some lymphocytes are infiltrated,
while others are not. It follows that the algorithm cannot
distinguish between subjects that have lymphocytes close to
cancer cells deep in the tumor, from those that only have
lymphocytes in the stroma environment at the interface with
the tumor, without any sort of infiltration (in both cases,
corresponding histograms would show a peak in low positive
bins).
This notion of infiltration of lymphocytes within the tumor
has however been introduced into features f (2) and f (5),
which correlate with survival with high confidence. The former
feature captures the distance between lymphocytes and the
tumor/stroma interface, associating a negative distance when
lymphocytes are located in the tumor environment. The latter
can be understood as a refinement of the former, and measures
the density of lymphocytes among cells as distance to that
interface increases. Again, a negative distance distinguishes
bands that are within the tumor environment from those that
are within the stroma environment.
When looking in more details at central histograms in Figure
3 (bottom), it reveals that both subjects seem to have both
infiltrating and non-infiltrating lymphocytes. The absence of
bins around distance 0µm is an artifact of the method used
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Fig. 3. Survival curves associated with both sub-populations S(2)1 and S(2)2 obtained by AHC using D(2) (top); histogram H(2)s∗1 associated with the most
central subject s∗1 ∈ S(2)1 (alive, TTLFU 2973 days) of the first sub-population S(2)1 , obtained by feeding D(2) to the AHC clustering algorithm (left); and
corresponding histogram H(2)
s∗2
of the central subject s∗2 ∈ S(2)2 (alive, TTLFU 670 days) of the other sub-population S(2)2 (right).
to determine the cancer/stroma interface. By construction,
a triangle in the Delaunay triangulation of cells is part of
the interface if it links at least one cancer and one stroma
cell (see Section III-B). As a consequence, lymphocytes are
not used to define the border, which leads to this artifact.
A noticeable difference between both histograms is that the
central subject in the homogeneous sub-population S(2)1 has
a less deep lymphocyte infiltration (around −40µm) than
the central subject in the heterogeneous sub-population S(2)2
(around −80µm). When looking at the corresponding survival
curves in Figure 3 (top), it reveals that subjects in the cluster
S(2)2 have a better survival prognosis than the other ones,
which matches known facts regarding the link between TILs
and survival outcome [6]. In order to verify if that observation
generalizes to all subjects within the clusters – and not only
to the central subjects –, we have listed the minimum distance
per histogram and have analyzed the distributions of such
values per cluster. We obtain for cluster S(2)1 a mean of
−43.29µm, with standard deviation 20.56µm; and for cluster
S(2)2 a mean of−112.66µm, with standard deviation 75.60µm.
Mann-Whitney U test [17] indicates that both distributions
are statistically significant (U = 201, p-value = 1.85e − 09),
which validates the observation.
A similar observation can be done with feature f (5). His-
tograms in Figure 6 show that the cental subject of the homo-
geneous cluster S(5)1 , which has a poorer survival prognosis,
has a less deep infiltration of lymphocytes (around −30µm)
when compared with the central subject of the heterogeneous
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Fig. 4. Survival curves associated with both sub-populations S(3)1 and S(3)2 obtained by AHC using D(3) (top); histogram H(3)s∗1 associated with the most
central subject s∗1 ∈ S(3)1 (alive, TTLFU 938 days) of the first sub-population S(3)1 , obtained by feeding D(3) to the AHC clustering algorithm (left); and
corresponding histogram H(3)
s∗2
of the central subject s∗2 ∈ S(3)2 (alive, TTLFU 1523 days) of the other sub-population S(3)2 (right).
cluster S(5)2 (around −70µm). As for feature f (2), we have
listed minimum band per histogram and have analyzed the
distributions of such values per cluster. We obtain for cluster
S(5)1 a mean of −27µm, with standard deviation 5.6µm; and
for cluster S(2)2 a mean of −87µm, with standard deviation
53.6µm. Mann-Whitney U test indicates that both distributions
are statistically significant (U = 7.5, p-value = 3.56e − 11),
which confirms what has been discussed in the previous
paragraph.
Features f (3) and f (4) consider a coarser scale in the tissue,
and study the link between presence of aggregates of lympho-
cytes at the tumor periphery and overall survival. The former
feature captures the distances between aggregates, while the
latter simply studies the distribution of the sizes of these
aggregates. It can be seen in Figure 4 that the central subject
in the homogeneous cluster S(3)1 has a maximum distance
between aggregates of lymphocytes (around 180µm) which is
much lower than for the central subject of the heterogeneous
cluster S(3)2 (around 390µm). Survival curves show that the
heterogeneous sub-population has a poorer survival prognosis.
A closer analysis at histograms reveals that subjects from the
homogeneous cluster have aggregates of lymphocytes that are
in general close to one another, suggesting a uniform reparti-
tion of aggregates of lymphocytes to fight tumor progression,
which denotes an efficient immune response. We have listed
the maximum inter-aggregate distance per histogram and have
analyzed the distributions of such values per cluster. We obtain
for cluster S(3)1 a mean of 309.63µm, with standard deviation
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Fig. 5. Survival curves associated with both sub-populations S(4)1 and S(4)2 obtained by AHC using D(4) (top); histogram H(4)s∗1 associated with the most
central subject s∗1 ∈ S(4)1 (alive, TTLFU 418 days) of the first sub-population S(4)1 , obtained by feeding D(4) to the AHC clustering algorithm (left); and
corresponding histogram H(4)
s∗2
of the central subject s∗2 ∈ S(4)2 (alive, TTLFU 487 days) of the other sub-population S(4)2 (right).
213.06µm; and for cluster S(3)2 a mean of 431.16µm, with
standard deviation 274.72µm. Mann-Whitney U test indicates
that both distributions are statistically significant (U = 611,
p-value = 0.008), which validates the observation.
In addition to this analysis of repartition of aggregates
of lymphocytes, Figure 5 shows us that the size of these
aggregates is important for survival prognosis. As a matter
of fact, it can be seen that the most central subject of
the homogeneous cluster S(4)1 has aggregates that are a lot
smaller (maximum around 86µm) than those of the central
subject of the heterogeneous cluster S(4)2 (maximum around
850µm). Since subjects in the homogeneous cluster have a
poorer survival prognosis, this suggests that presence of large
aggregates of lymphocytes may be characteristic of an efficient
immune response. We have listed the maximum aggregate size
per histogram and have analyzed the distributions of such
values per cluster. We obtain for cluster S(4)1 a mean of 300.35
lymphocytes in the largest aggregate, with standard deviation
491.56; and for cluster S(4)2 a mean of 1773.97 lymphocytes in
the largest aggregate, with standard deviation 1579.39. Mann-
Whitney U test indicates that both distributions are statistically
significant (U = 192.5, p-value = 7.17e−10), which validates
the observation.
Finally, Figure 7 shows that the matrix of weighted co-
occurrences of subjects within clusters significantly separates
the two survival curves. This suggests that sub-populations
produced tend to be coherent across features, especially for
subjects that die after a very short period. As a consequence,
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Fig. 6. Survival curves associated with both sub-populations S(5)1 and S(5)2 obtained by AHC using D(5) (top); histogram H(5)s∗1 associated with the most
central subject s∗1 ∈ S(5)1 (alive, TTLFU 773 days) of the first sub-population S(5)1 , obtained by feeding D(5) to the AHC clustering algorithm (left); and
corresponding histogram H(5)
s∗2
of the central subject s∗2 ∈ S(5)2 (dead, TTLFU 47 days) of the other sub-population S(5)2 (right).
this aggregation method offers an interesting approach to
estimate survival prognosis based on a multi-criteria analysis.
VI. CONCLUSION
In this article, we have proposed a methodology that allows
comparing and clustering subjects on the basis of complex
attributes, which capture their repartitions of cells within
biopsies. To motivate our approach, we have introduced five
features, each capturing some information on spatial reparti-
tions of cells, and have shown that our method could produce
clusters that are significantly different, while offering some
interpretability of the results. We have illustrated our method
on a dataset of H&E biopsies of subjects suffering from Stage
I lung adenocarcinoma, and have been able to find clusters that
match existing knowledge in survival prognosis estimation.
Our method therefore offers a novel way of integrating
complex features in survival analysis, in an automatic way.
This allows one to explore new hypotheses regarding the
links between cell organization patterns and survival outcome,
and offers a systemic method for comparing two subjects
on the basis of their personal attributes, which can help
suggest someone a treatment that was efficient to a similar
subject. Additionally, our method provides pathologists with
very readable histograms of complex organizations of cells (or
coarser elements such as cell aggregates) within tissues, which
can be very difficult to assess by human eye. Our approach can
thus help them produce a more detailed and quicker diagnosis,
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Fig. 7. Survival curves associated with both sub-populations S1 and S2 obtained by AHC using D.
thus reducing the time between diagnosis and treatment of the
cancer.
Perspective for extending this work are numerous. One
direction consists in extending our catalogue of features to
discover new distributions that may correlate with prognosis.
Another direction is to evaluate our methodology on more
complex data, such as mIHC, and other families of cancers.
Finally, we want to explore variations of the elements in our
approach, such as using different clustering algorithms, or
changing the number of sub-populations produced, in case we
manipulate a database of subjects with more than two profiles.
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